日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibiotic Prophylaxis Strategies and Surgical Site Infections in Colorectal Surgery: A Systematic Review and Network Meta-Analysis

结直肠手术中抗生素预防策略与手术部位感染:系统评价和网络荟萃分析

Motaghi, Shahrzad; Karam, Samer G; Mulazzani, Francesca; Mirzayeh Fashami, Fatemeh; Buchan, Tayler A; Ibrahim, Sara; Moradi Falah Langeroodi, Shahryar; Khademioore, Sahar; Couban, Rachel J; Mbuagbaw, Lawrence; Mertz, Dominik; Loeb, Mark

Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis

轻症或中症新冠肺炎药物治疗:系统评价和网络荟萃分析

Ibrahim, Sara; Siemieniuk, Reed A C; Oliveros, María José; Islam, Nazmul; Díaz Martinez, Juan Pablo; Izcovich, Ariel; Qasim, Anila; Zhao, Yunli; Zaror, Carlos; Yao, Liang; Wang, Ying; Vandvik, Per O; Roldan, Yetiani; Rochwerg, Bram; Rada, Gabriel; Prasad, Manya; Pardo-Hernandez, Hector; Mustafa, Reem A; Fashami, Fatemeh Mirzayeh; Miroshnychenko, Anna; McLeod, Shelley L; Mansilla, Cristian; Lamontagne, Francois; Khosravirad, Azin; Honarmand, Kimia; Ghadimi, Maryam; Gao, Ya; Foroutan, Farid; Devji, Tahira; Couban, Rachel; Chu, Derek K; Chowdhury, Saifur Rahman; Chang, Yaping; Bravo-Soto, Gonzalo; Bosio, Claudia; Biscay, Diana; Bhogal, Gurleen; Azab, Maria; Agoritsas, Thomas; Agarwal, Arnav; Guyatt, Gordon H; Brignardello-Petersen, Romina

Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023

医疗决策中的间接治疗比较:2021-2023年全球肿瘤药物监管审批、报销和定价建议的重点回顾

Igarashi, Ataru; Tanaka, Shiro; De Moor, Raf; Li, Nan; Hirozane, Mariko; Wu, David Bin-Chia; Hong, Li Wen; Yu, Dae Young; Hashim, Mahmoud; Hutton, Brian; Tantakoun, Krista; Olsen, Christopher; Fashami, Fatemeh Mirzayeh; Samjoo, Imtiaz A; Cameron, Chris

Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023

更正:医疗保健决策中的间接治疗比较:2021-2023年全球肿瘤药物监管审批、报销和定价建议的针对性审查

Igarashi, Ataru; Tanaka, Shiro; De Moor, Raf; Li, Nan; Hirozane, Mariko; Wu, David Bin-Chia; Hong, Li Wen; Yu, Dae Young; Hashim, Mahmoud; Hutton, Brian; Tantakoun, Krista; Olsen, Christopher; Fashami, Fatemeh Mirzayeh; Samjoo, Imtiaz A; Cameron, Chris

Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials

安非他明和甲基苯丙胺使用障碍的管理:随机试验的系统评价和网络荟萃分析

Khalili, Malahat; Sadeghirad, Behnam; Bach, Paxton; Crabtree, Alexis; Javadi, Sara; Sadeghi, Erfan; Moradi, Sara; Mirzayeh Fashami, Fatemeh; Nakhaeizadeh, Mehran; Salehi, Sahar; Sofi-Mahmudi, Ahmad; Nasiri, Naser; Mehmandoost, Soheil; Moallef, Soroush; Langeroodi, Shahryar Moradi Falah; Moe, Jessica; Lysyshyn, Mark; Werb, Dan; Buxton, Jane A; Karamouzian, Mohammad

Isolation, characterization, therapeutic and prophylactic applications of a lytic bacteriophage to combat multi-drug resistance Shigella flexneri: an animal study model

利用溶菌噬菌体分离、鉴定、治疗和预防多重耐药性福氏志贺氏菌:动物研究模型

Abbasi Fashami, Parisa; Pournajaf, Abazar; Amirmozafari, Nour; Hallajzadeh, Masoume; Mahabadi, Vahid Pirhajati; Saghiri, Reza; Khafri, Soraya; Golmoradi Zadeh, Rezvan; Akrami, Sousan; Asgharzadeh, Sajjad; Rajabnia, Mehdi

Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials

钠-葡萄糖协同转运蛋白2抑制剂治疗2型糖尿病患者的骨折风险:一项更新的随机对照试验荟萃分析

Banisi, Mahdieh Khoshzaban; Emami, Ehsan; Varjovi, Mahdiyeh Nozad; Kia, Alireza Shayesteh; Rasaiyan, Mahtab; Fashami, Shayan Agha Amini; Shirazi, Niloofar; Ahsan, Elahe; Deravi, Niloofar; Naziri, Mahdyieh; Zarei, Roza; Shabani, Niloufar

Improving the reproductive health literacy of couples on the verge of marriage through the FOCUS-PDCA model: Mixed-method study

通过FOCUS-PDCA模型提高即将结婚夫妇的生殖健康素养:混合方法研究

Dabiri, Fatemeh; Hajian, Sepideh; Zayeri, Farid; Hosseini Teshnizi, Saeed; Abbasi Fashami, Mahta

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

出版商更正:2018年至2022年加拿大非肿瘤药物卫生技术评估报告:对制造商提交材料的方法论批判以及制造商与加拿大药品和技术卫生机构(CADTH)分析的比较

Mirzayeh Fashami, Fatemeh; Tarride, Jean-Eric; Sadeghirad, Behnam; Hariri, Kimia; Peyrovinasab, Amirreza; Levine, Mitchell

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

2018年至2022年加拿大非肿瘤药物卫生技术评估报告:对制造商提交材料的方法论批判以及制造商分析与加拿大药品和技术卫生机构(CADTH)分析的比较

Mirzayeh Fashami, Fatemeh; Tarride, Jean-Eric; Sadeghirad, Behnam; Hariri, Kimia; Peyrovinasab, Amirreza; Levine, Mitchell